Discover the world of Recursive Self-Improvement (RSI) in AI. From I.J. Good's intelligence explosion to modern self-healing code and clinical applications, explore who is developing it, how it works, ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

While everyone is discussing are we in an AI bubble or not, Harvard is teaching how to invest in these irrational times.

The Nasdaq Foundation's Economic Opportunity Grant Program drives impact through five key areas—regional revitalization and rural wealth building, access to capital, employee and community ownership, ...

Elon Musk's SpaceX has officially acquired another one of his companies, xAI. The technologist announced the deal in ...

The Business of Biotech was back in San Francisco for JPM in January, and offers here a few observations, highlights, and ...

There’s a new essay out from one half of the Amodei duo that created Anthropic, a firm often billed as a kinder, gentler AI ...

Access detailed historical stock prices, including daily closing prices, for RXRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...